Taiwanese drug maker Adimmune Corp. on Thursday said it has started the first phase of human trials for its experimental COVID-19 vaccine this week, with Phase 2 likely to follow in November if everything goes well.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
DPP township council candidate dies after collapsing on stage
09/23/2026 11:52 AM - Science & Tech
Taiwan part of WorldSkills Competition opening ceremony in China
09/23/2026 10:53 AM - Business
U.S. dollar down in Taipei trading
09/23/2026 10:17 AM - Society
Taiwan headline news
09/23/2026 10:05 AM - Business
Taiwan shares open higher
09/23/2026 09:15 AM